Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

products, or our ability to generate revenue from sales of these products may be significantly delayed.  Further, if we are not successful in generating sufficient revenue, raising additional capital or securing partnership arrangements, we will not be able to complete the actual use study for our ibuprofen product or commercialize our pseudoephedrine product, and we may be required to further curtail or cease our operations. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the Securities and Exchange Commission, including the "Risk Factors" set forth in our Annual Report on Form 10-K, as supplemented by our quarterly reports on Form 10-Q. Such filings are available on our website or at www.sec.gov. You are cautioned that such statements are not guarantees of future performance and that actual result or developments may differ materially from those set forth in the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstance.SCOLR Pharma, Inc.CONDENSED BALANCE SHEETS
(In thousands, except par values and number of shares)
(Unaudited)September 30,
2010December 31, 2009ASSETSCurrent AssetsCash and cash equivalents$

2,439$

1,176Accounts receivable125269Inventory129—Prepaid expenses and other assets414228Total current assets3,1071,673Property and Equipment — net of accumulated depreciation of $1,386 and $1,272, respectively356435Intangible assets — net of accumulated amortization of $584 and $514, respectively731565Restricted cash275438$

4,469$

3,111LIABILITIES AND STOCKHOLDERS' EQUITYCurrent LiabilitiesAccounts payable$

76$

47Accrued liabilities282640Deferred revenue —25Total current liabilities358712Deferred rent 168198Total liabilities526910Commitm
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 24, 2015 Hospira, Inc. (NYSE: ... of biosimilar therapies, spoke about the importance of extrapolation ... Generics Association (EGA) annual European Biosimilars Group conference in ... also announced the publication of a pivotal white paper ... full promise of biosimilars." Speaking at ...
(Date:4/24/2015)... Mass. , April 24, 2015  Blueprint ... BLU-554, a selective and potent inhibitor of fibroblast ... activity in models of hepatocellular carcinoma (HCC) that ... therapeutic candidate, BLU-554 induced complete tumor regression in ... an FGFR4-activating ligand at the highest dose levels. ...
(Date:4/23/2015)... IRVINE, Calif., April 23, 2015  Edwards Lifesciences Corporation (NYSE: ... of heart valves and hemodynamic monitoring, today reported net ... million, or $1.12 per diluted share.  Net income for ... or $0.56 per diluted share, and non-GAAP net income ... Net sales for the quarter ended March 31, 2015 ...
Breaking Medicine Technology:Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16
...  Reportlinker.com announces that a new market ... catalogue: Triple Analysis: ... http://www.reportlinker.com/p0284888/Triple-Analysis-Apoptosis-Cancer-Vaccines-and-Antibodies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This ... development strategies by the two mechanism/target/effect ...
... Research Institute (IDRI) announces today that GlaxoSmithKline (GSK) Biologicals ... equipment that will assist IDRI as it designs and ... the developing world. IDRI will apply the gift as ... tuberculosis, leishmaniasis, malaria, leprosy, and pandemic influenza. ...
Cached Medicine Technology:Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies 2Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies 3Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies 4Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies 5GlaxoSmithKline Donates Scientific Equipment to Advance IDRI's Global Health Mission 2
(Date:4/24/2015)... Carinsurancequotesinfo.com has released a new blog ... to qualify for auto insurance as a ... auto insurance online, without having to follow a special ... parents can reduce their auto insurance expenses. The tips ... explained. , Clients can now visit an insurance ...
(Date:4/24/2015)... 24, 2015 Olive Fertility Centre is ... co-founder and co-director, has been honoured for his pioneering ... Evening of Hope Gala. , “We are very ... Yuzpe, who has been at the forefront of fertility ... Jessica Séguin, Executive Director of Fertile Futures--a Canadian non-profit ...
(Date:4/24/2015)... April 24, 2015 Insuranceautoquote.info has released ... car insurance premiums . , Lowering auto insurance ... quotes to simply find better offers for their financial ... and it does not require any registration. , ... coverage. There are multiple agencies that sell coverage and ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 “ Opera ” ... Report, which features the latest and coolest technology products available ... of NewsWatch, conducted the review and shared with viewers how ... Without web browsers, surfing the internet would not be in ... other and the Opera browser is no different. Celebrating their ...
(Date:4/24/2015)... 24, 2015 Eastern Star Masonic Home is ... Room on Sunday April 26th from 1:30-3:00 pm. , Residents ... the ribbon cutting and grand opening of the new community ... on hand to offer tours to anyone who wishes to ... The new community room will be available for use by ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2Health News:Car Insurance Quotes Can Help Drivers Lower Their Premiums 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2
... NEWPORT BEACH, Calif., July 16 Nationwide Health Properties, Inc. ... its 2009 second quarter results on Wednesday, August 5, 2009 after the ... will host a webcast and conference call on Thursday, August 6, 2009 ... results. , , The webcast can be ...
... Health (International) Limited, a wholly owned subsidiary of BELLUS ... the Italian Ministry of Health has granted a certificate ... supplement. A certificate of free sale in Italy permits ... This certificate opens up means by which to pursue ...
... , BOCA RATON, Fla., July 16 ... a further update of the status of its acquisition of ... The closing date for the acquisition, currently scheduled for a ... to a date on or before July 24, 2009 to ...
... CAMBRIDGE, Mass., July 16 Biopure Corporation (Nasdaq: ... petition for relief under Chapter 11 of the United States Bankruptcy ... Massachusetts. Biopure will continue to manage and operate its businesses ... the supervision of the Bankruptcy Court. , , ...
... SAN FRANCISCO, July 16 Litigation and insurance coverage ... from China is the focus of a half-day seminar 7:30 am ... Conference Center at the University of California San Francisco. The ... The conference producer, HB Litigation Conferences LLC, has selected the ...
... , , DETROIT, July 16 ... looking for alternative options to decrease spending without losing employee coverage. ... coverage for their employees and lower their costs by as much ... , , An HRA ...
Cached Medicine News:Health News:NHP Announces Second Quarter Earnings Release Date and Webcast/Conference Call 2Health News:VIVIMIND(TM) granted certificate of free sale as food supplement in Italy - Premarket notification filed in the U.S. 2Health News:VIVIMIND(TM) granted certificate of free sale as food supplement in Italy - Premarket notification filed in the U.S. 3Health News:JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc. 2Health News:Chinese Drywall Litigation & Insurance Conference July 28 in San Francisco 2Health News:How To Reduce Cost Without Sacrificing Your Health Coverage 2
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
... The Criterion Dodeca cell, a component of ... run up to 12 Criterion gels in a ... (13.3 x 8.7 cm) than the traditional mini ... strips to give you the optimal combination of ...
... Dodeca cell accommodates up to 12 large ... runs in the PROTEAN IEF system, for ... The PROTEAN Plus Dodeca cell's cooling and ... allow consistent, high-resolution results. The handcasting system ...
... ElectroXpress gel electrophoresis system mirrors a 96-well ... screening of PCR products to take place ... source (96-well) plate. Loading can be carried out ... first time in the industry two sets ...
Medicine Products: